| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |